Ceramide biomarkers predictive of cardiovascular disease risk increase in healthy older adults after bed rest

JJ Petrocelli, AI McKenzie… - The Journals of …, 2020 - academic.oup.com
Acute bed rest places older adults at risk for health complications by disrupting homeostasis
in many organ systems, including the cardiovascular system. Circulating ceramides are …

You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease

JV Varre, WL Holland, SA Summers - … (BBA)-Molecular and Cell Biology of …, 2022 - Elsevier
Obesity leads to persistent increases in immune responses that contribute to
cardiometabolic pathologies such as diabetes and cardiovascular disease. Pro …

[HTML][HTML] Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway [S]

NB Blackburn, LF Michael, PJ Meikle, JM Peralta… - Journal of lipid …, 2019 - ASBMB
The de novo ceramide synthesis pathway is essential to human biology and health, but
genetic influences remain unexplored. The core function of this pathway is the generation of …

[HTML][HTML] Bioactive sphingolipids as major regulators of coronary artery disease

JH Song, GT Kim, KH Park, WJ Park… - Biomolecules & …, 2021 - ncbi.nlm.nih.gov
Atherosclerosis is the deposition of plaque in the main arteries. It is an inflammatory
condition involving the accumulation of macrophages and various lipids (low-density …

[HTML][HTML] Precision diagnostic approach to predict 5-year risk for microvascular complications in type 1 diabetes

N Al-Sari, S Kutuzova, T Suvitaival, P Henriksen… - …, 2022 - thelancet.com
Background Individuals with long standing diabetes duration can experience damage to
small microvascular blood vessels leading to diabetes complications (DCs) and increased …

Myriocin and d-PDMP ameliorate atherosclerosis in ApoE−/− mice via reducing lipid uptake and vascular inflammation

Z Yu, Q Peng, S Li, H Hao, J Deng, L Meng… - Clinical …, 2020 - portlandpress.com
Sphingolipids have been implicated in the etiology of atherosclerosis. The commonly used
sphingolipid inhibitors, myriocin (a ceramide inhibitor) and d-PDMP (d-threo-1-phenyl-2 …

[HTML][HTML] How ceramides orchestrate cardiometabolic health—an ode to physically active living

J Carrard, H Gallart-Ayala, N Weber, F Colledge… - Metabolites, 2021 - mdpi.com
Cardiometabolic diseases (CMD) represent a growing socioeconomic burden and concern
for healthcare systems worldwide. Improving patients' metabolic phenotyping in clinical …

Interplay between ceramides and phytonutrients: New insights in metabolic syndrome

MA Shabbir, F Mehak, ZM Khan, W Ahmad… - Trends in Food Science …, 2021 - Elsevier
Background Ceramides are a novel biomarker for numerous obesity-associated disorders
such as type II diabetes mellitus (T2D) and atherosclerosis. Ceramides were considered as …

Sphingolipids

AH Futerman - Biochemistry of lipids, lipoproteins and membranes, 2021 - Elsevier
Sphingolipids are ubiquitous components of eukaryotic cell membranes and have been
widely studied over the past couple of decades due to the discovery of their involvement in a …

[HTML][HTML] Potential Drug Targets for Ceramide Metabolism in Cardiovascular Disease

J Guo, J Feng, H Qu, H Xu, H Zhou - Journal of Cardiovascular …, 2022 - mdpi.com
Cardiovascular disease poses a significant threat to the quality of human life. Metabolic
abnormalities caused by excessive caloric intake have been shown to lead to the …